Abiopharma

News list

📋 Katherine Weymouth (Director) plans to sell 5K shares of Xometry Inc. (at $95.23 each, total $476K) Filed: Aug 31, 2026 | ID: 000968

Full text

News bot Aug. 31, 2026, 8:01 p.m.
📋 Form 144 Filing: Katherine Weymouth

Company: Xometry Inc.

Filing Date: 2026-08-31

Relationship: Director
Planned Sale Details:
- Security: Class A Common
- Shares to be Sold: 5,000
- Price per Share: $95.23
- Total Value: $476,150.00
- Planned Sale Date: 2026-08-31
- Broker: UBS Financial Services Inc
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-40546
- Issuer Contact Phone: 240-252-1138
- Issuer Address: 6116 Executive Blvd, Suite 800, Rockville, MD, 20852
- Broker Address: 1000 Harbor Blvd, 3rd Floor, Weehawken, NJ, 07086
- Shares Outstanding: 55848262.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 1
- Signature: /s/JOSEPH CASSIDY, for UBS Financial Services Inc, as attorney-in-fact for Katherine Weymouth